Home : ELEVATE Study Aims to Improve Selection Criteria and Outcomes for Patients with Severe Emphysema Treated with the PneumRx™ Endobronchial Coil System |
|
Jun 11 2018 |
ELEVATE Study Aims to Improve Selection Criteria and Outcomes for Patients with Severe Emphysema Treated with the PneumRx™ Endobronchial Coil System |
LONDON, June 11, 2018 /PRNewswire/ --
Recruitment Begins in 7 European Countries
BTG plc (LSE: BTG), the global healthcare company, today announces the start of ELEVATE: A randomizEd ControlLed Study of PnEumRx™ Endobronchial Coil System (Coils) Versus Standard of Care Medical... |
|
|
Source:https://www.prnewswire.com/news-releases/elevate-study-aims-to-improve-selection-criteria-and-outcomes-for-patients-with-severe-emphysema-treated-with-the-pneumrx-endobronchial-coil-system-685096331.html |
|
Related News
|
» The9 Limited Regains Compliance with Nasdaq Listing Requirements » Infogram expandiert nach Akquisition durch Prezi in der DACH-Region |